human | Q5 |
P496 | ORCID iD | 0000-0002-5044-9610 |
P69 | educated at | Karolinska Institutet | Q219564 |
P108 | employer | Karolinska Institutet | Q219564 |
P734 | family name | Lindén | Q4276862 |
Lindén | Q4276862 | ||
Lindén | Q4276862 | ||
P735 | given name | Magdalena | Q842544 |
Magdalena | Q842544 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q35304183 | Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655. |
Q37322100 | Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis |
Q55401408 | DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. |
Q45364835 | Epstein-Barr virus and multiple sclerosis: interaction with HLA. |
Q47564983 | Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients |
Q57224299 | Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis |
Q46054080 | Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13. |
Q57224383 | No evidence of IL21 association with multiple sclerosis in a Swedish population |
Search more.